Patent · US Active

Extended release pharmaceutical composition of entacapone or salts thereof

US9289392B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

Wockhardt Limited · IN

Inventors

Ritesh Kapoor · Mandi, IN
Munish Talwar · Aurangabad, IN
Sanjay Mate · Aurangabad, IN
Manoj Mashalkar · Latur, IN
Girish Kumar Jain · Ashti, IN
Mandar Kodgule · Mumbai, IN

Key dates

Filing date	Aug 22, 2009
Grant date	Mar 22, 2016
Priority date	—
Expiry date	Sep 24, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided an extended release pharmaceutical composition comprising from about 200 mg to about 1000 mg of entacapone or salts thereof, optionally with other pharmaceutically acceptable excipients. The invention also provides an extended release pharmaceutical composition comprising triple combination of from about 30 mg to about 300 mg of levodopa, 10 mg to about 100 mg of carbidopa and 200 mg to about 1000 mg of entacapone or salts thereof, optionally with other pharmaceutically acceptable excipients. The invention also relates to process of preparation of such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.